Addiction is complex and multifaceted, and recovery isn’t one-size-fits-all; one must often delve into the nature of a person’s drug of choice to develop an
The pharmaceutical giant and its subsidiary are facing legal action over the anti-psychotic drug.
A federal judge recently denied a motion by Purdue Pharma LP to reconsider dismissing a lawsuit.
More complaints have been filed against the drugmakers regarding nerve damage risks linked to the antibiotic drug Avelox.
A federal judge in Pennsylvania has denied a bid by Cephalon Inc. to dismiss claims in a lawsuit filed over marketing the drug.
Addiction is complex and multifaceted, and recovery isn’t one-size-fits-all; one must often delve into the nature of a person’s drug of choice to develop an
The pharmaceutical giant and its subsidiary are facing legal action over the anti-psychotic drug.
A federal judge recently denied a motion by Purdue Pharma LP to reconsider dismissing a lawsuit.
More complaints have been filed against the drugmakers regarding nerve damage risks linked to the antibiotic drug Avelox.
A federal judge in Pennsylvania has denied a bid by Cephalon Inc. to dismiss claims in a lawsuit filed over marketing the drug.
